Global Chromoendoscopy Agents Market

Chromoendoscopy Agents Comprehensive Study by Type (Absorptive Agent, Contrast Agent, Reactive Agent), Application (Colorectal, Esophageal, Gastric), By End User (Ambulatory Surgical Center, Diagnostic Center, Hospital, Specialty Clinics, Others) Players and Region - Global Market Outlook to 2028

Chromoendoscopy Agents Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Chromoendoscopy Agents Market Overview:
Chromoendoscopy is the effective use of stains or pigments to further develop tissue confinement, portrayal, or finding during endoscopy. Chromoendoscopy has been applied in an arrangement of clinical settings and all through the gastrointestinal part. The advancement of technologies like endoscopic mucosal resection and photodynamic treatment that require exact visual tissue portrayal that raises interest in chromoendoscopy. Also, chromoendoscopy is being utilized related to different advances in endoscopic imaging, like amplification endoscopy, confocal endomicroscopy, and confocal endocytoscopy.

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
The increasing geriatric population across the globe and Growing technological advancements by increasing adoption of advanced medical techniques

Market Growth Drivers:
Rise in the number of endoscopy procedures across different developed and developing economies and Increase in prevalence of chronic diseases across the globe

Challenges:
Stringent government rules and regulations regarding the research and development and application of invented methodologies and technologies and High cost of research and development with lack of infrastructure in developing countries

Restraints:
Lack of skilled and experienced endoscopists and professionals and The wide gap in knowledge and skills because biotechnology is growing with the advancements of medical techniques

Opportunities:
Growing Research and Development activities regarding healthcare and concerning technology in developing countries, Increase awareness regarding cancer in different developing countries and The government of developed and developing countries is increasing the healthcare expenditure budget

Competitive Landscape:
The Chromoendoscopy Agents market is engaged with different players in the market. These organizations avail competitive advantage, apply strategic collaborations with companies, and generates an opportunity to expand their business activities in developing countries. Also, organizations are increasing investment in research and development activities to develop new products as well as the development of new technology.
Some of the key players profiled in the report are American Regent, Inc. (United States), Cerba Research (Belgium), Cosmo Pharmaceuticals NV. (Ireland), Enzo Life Sciences, Inc. (United States), LobaChemie Pvt. Ltd. (India), Merck KGaA (Germany), Micro-Tech Endoscopy (United States), Provepharm Life Solutions (France), Sisco Research Laboratories Pvt. Ltd. (India) and Thermo Fisher Scientific (United States). Additionally, following companies can also be profiled that are part of our coverage like Histalim (France), Medtronic plc. (Ireland) and Boston Scientific (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Chromoendoscopy Agents market by 2028. Considering Market by By End User, the sub-segment i.e. Ambulatory Surgical Center will boost the Chromoendoscopy Agents market.

In 2021, Cerba Research, a leading global clinical trial laboratory services organization owned by Cerba HealthCare, announced that they have joined forces with ACT Genomics under a joint venture model to create a purpose-built lab facility in Taiwan covering the Asia Pacific region. This expansion of the precision medicine offering includes central labs, flow cytometry, histopathology, and translational science laboratory services.

What Can be Explored with the Chromoendoscopy Agents Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Chromoendoscopy Agents Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Chromoendoscopy Agents
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Chromoendoscopy Agents market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Chromoendoscopy Agents market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Industry Associations, Government Regulatory Authority, Government Research and Development Institutions, Private Research Organizations, Health Sector Technology Manufacturer and Supplier and Other.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Absorptive Agent
  • Contrast Agent
  • Reactive Agent
By Application
  • Colorectal
  • Esophageal
  • Gastric
By By End User
  • Ambulatory Surgical Center
  • Diagnostic Center
  • Hospital
  • Specialty Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in the number of endoscopy procedures across different developed and developing economies
      • 3.2.2. Increase in prevalence of chronic diseases across the globe
    • 3.3. Market Challenges
      • 3.3.1. Stringent government rules and regulations regarding the research and development and application of invented methodologies and technologies
      • 3.3.2. High cost of research and development with lack of infrastructure in developing countries
    • 3.4. Market Trends
      • 3.4.1. The increasing geriatric population across the globe
      • 3.4.2. Growing technological advancements by increasing adoption of advanced medical techniques
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Chromoendoscopy Agents, by Type, Application, By End User and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Chromoendoscopy Agents (Value)
      • 5.2.1. Global Chromoendoscopy Agents by: Type (Value)
        • 5.2.1.1. Absorptive Agent
        • 5.2.1.2. Contrast Agent
        • 5.2.1.3. Reactive Agent
      • 5.2.2. Global Chromoendoscopy Agents by: Application (Value)
        • 5.2.2.1. Colorectal
        • 5.2.2.2. Esophageal
        • 5.2.2.3. Gastric
      • 5.2.3. Global Chromoendoscopy Agents by: By End User (Value)
        • 5.2.3.1. Ambulatory Surgical Center
        • 5.2.3.2. Diagnostic Center
        • 5.2.3.3. Hospital
        • 5.2.3.4. Specialty Clinics
        • 5.2.3.5. Others
      • 5.2.4. Global Chromoendoscopy Agents Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Chromoendoscopy Agents: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. American Regent, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cerba Research (Belgium)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cosmo Pharmaceuticals NV. (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Enzo Life Sciences, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. LobaChemie Pvt. Ltd. (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck KGaA (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Micro-Tech Endoscopy (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Provepharm Life Solutions (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sisco Research Laboratories Pvt. Ltd. (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Thermo Fisher Scientific (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Chromoendoscopy Agents Sale, by Type, Application, By End User and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Chromoendoscopy Agents (Value)
      • 7.2.1. Global Chromoendoscopy Agents by: Type (Value)
        • 7.2.1.1. Absorptive Agent
        • 7.2.1.2. Contrast Agent
        • 7.2.1.3. Reactive Agent
      • 7.2.2. Global Chromoendoscopy Agents by: Application (Value)
        • 7.2.2.1. Colorectal
        • 7.2.2.2. Esophageal
        • 7.2.2.3. Gastric
      • 7.2.3. Global Chromoendoscopy Agents by: By End User (Value)
        • 7.2.3.1. Ambulatory Surgical Center
        • 7.2.3.2. Diagnostic Center
        • 7.2.3.3. Hospital
        • 7.2.3.4. Specialty Clinics
        • 7.2.3.5. Others
      • 7.2.4. Global Chromoendoscopy Agents Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Chromoendoscopy Agents: by Type(USD Million)
  • Table 2. Chromoendoscopy Agents Absorptive Agent , by Region USD Million (2017-2022)
  • Table 3. Chromoendoscopy Agents Contrast Agent , by Region USD Million (2017-2022)
  • Table 4. Chromoendoscopy Agents Reactive Agent , by Region USD Million (2017-2022)
  • Table 5. Chromoendoscopy Agents: by Application(USD Million)
  • Table 6. Chromoendoscopy Agents Colorectal , by Region USD Million (2017-2022)
  • Table 7. Chromoendoscopy Agents Esophageal , by Region USD Million (2017-2022)
  • Table 8. Chromoendoscopy Agents Gastric , by Region USD Million (2017-2022)
  • Table 9. Chromoendoscopy Agents: by By End User(USD Million)
  • Table 10. Chromoendoscopy Agents Ambulatory Surgical Center , by Region USD Million (2017-2022)
  • Table 11. Chromoendoscopy Agents Diagnostic Center , by Region USD Million (2017-2022)
  • Table 12. Chromoendoscopy Agents Hospital , by Region USD Million (2017-2022)
  • Table 13. Chromoendoscopy Agents Specialty Clinics , by Region USD Million (2017-2022)
  • Table 14. Chromoendoscopy Agents Others , by Region USD Million (2017-2022)
  • Table 15. South America Chromoendoscopy Agents, by Country USD Million (2017-2022)
  • Table 16. South America Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 17. South America Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 18. South America Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 19. Brazil Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 20. Brazil Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 21. Brazil Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 22. Argentina Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 23. Argentina Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 24. Argentina Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 25. Rest of South America Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 26. Rest of South America Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 27. Rest of South America Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 28. Asia Pacific Chromoendoscopy Agents, by Country USD Million (2017-2022)
  • Table 29. Asia Pacific Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 30. Asia Pacific Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 31. Asia Pacific Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 32. China Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 33. China Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 34. China Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 35. Japan Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 36. Japan Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 37. Japan Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 38. India Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 39. India Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 40. India Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 41. South Korea Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 42. South Korea Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 43. South Korea Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 44. Taiwan Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 45. Taiwan Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 46. Taiwan Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 47. Australia Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 48. Australia Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 49. Australia Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 50. Rest of Asia-Pacific Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 51. Rest of Asia-Pacific Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 52. Rest of Asia-Pacific Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 53. Europe Chromoendoscopy Agents, by Country USD Million (2017-2022)
  • Table 54. Europe Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 55. Europe Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 56. Europe Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 57. Germany Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 58. Germany Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 59. Germany Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 60. France Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 61. France Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 62. France Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 63. Italy Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 64. Italy Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 65. Italy Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 66. United Kingdom Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 67. United Kingdom Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 68. United Kingdom Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 69. Netherlands Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 70. Netherlands Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 71. Netherlands Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 72. Rest of Europe Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 73. Rest of Europe Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 74. Rest of Europe Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 75. MEA Chromoendoscopy Agents, by Country USD Million (2017-2022)
  • Table 76. MEA Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 77. MEA Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 78. MEA Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 79. Middle East Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 80. Middle East Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 81. Middle East Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 82. Africa Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 83. Africa Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 84. Africa Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 85. North America Chromoendoscopy Agents, by Country USD Million (2017-2022)
  • Table 86. North America Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 87. North America Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 88. North America Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 89. United States Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 90. United States Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 91. United States Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 92. Canada Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 93. Canada Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 94. Canada Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 95. Mexico Chromoendoscopy Agents, by Type USD Million (2017-2022)
  • Table 96. Mexico Chromoendoscopy Agents, by Application USD Million (2017-2022)
  • Table 97. Mexico Chromoendoscopy Agents, by By End User USD Million (2017-2022)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Chromoendoscopy Agents: by Type(USD Million)
  • Table 109. Chromoendoscopy Agents Absorptive Agent , by Region USD Million (2023-2028)
  • Table 110. Chromoendoscopy Agents Contrast Agent , by Region USD Million (2023-2028)
  • Table 111. Chromoendoscopy Agents Reactive Agent , by Region USD Million (2023-2028)
  • Table 112. Chromoendoscopy Agents: by Application(USD Million)
  • Table 113. Chromoendoscopy Agents Colorectal , by Region USD Million (2023-2028)
  • Table 114. Chromoendoscopy Agents Esophageal , by Region USD Million (2023-2028)
  • Table 115. Chromoendoscopy Agents Gastric , by Region USD Million (2023-2028)
  • Table 116. Chromoendoscopy Agents: by By End User(USD Million)
  • Table 117. Chromoendoscopy Agents Ambulatory Surgical Center , by Region USD Million (2023-2028)
  • Table 118. Chromoendoscopy Agents Diagnostic Center , by Region USD Million (2023-2028)
  • Table 119. Chromoendoscopy Agents Hospital , by Region USD Million (2023-2028)
  • Table 120. Chromoendoscopy Agents Specialty Clinics , by Region USD Million (2023-2028)
  • Table 121. Chromoendoscopy Agents Others , by Region USD Million (2023-2028)
  • Table 122. South America Chromoendoscopy Agents, by Country USD Million (2023-2028)
  • Table 123. South America Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 124. South America Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 125. South America Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 126. Brazil Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 127. Brazil Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 128. Brazil Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 129. Argentina Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 130. Argentina Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 131. Argentina Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 132. Rest of South America Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 133. Rest of South America Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 134. Rest of South America Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 135. Asia Pacific Chromoendoscopy Agents, by Country USD Million (2023-2028)
  • Table 136. Asia Pacific Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 137. Asia Pacific Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 138. Asia Pacific Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 139. China Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 140. China Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 141. China Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 142. Japan Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 143. Japan Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 144. Japan Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 145. India Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 146. India Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 147. India Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 148. South Korea Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 149. South Korea Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 150. South Korea Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 151. Taiwan Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 152. Taiwan Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 153. Taiwan Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 154. Australia Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 155. Australia Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 156. Australia Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 157. Rest of Asia-Pacific Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 158. Rest of Asia-Pacific Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 159. Rest of Asia-Pacific Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 160. Europe Chromoendoscopy Agents, by Country USD Million (2023-2028)
  • Table 161. Europe Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 162. Europe Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 163. Europe Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 164. Germany Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 165. Germany Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 166. Germany Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 167. France Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 168. France Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 169. France Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 170. Italy Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 171. Italy Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 172. Italy Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 173. United Kingdom Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 174. United Kingdom Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 175. United Kingdom Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 176. Netherlands Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 177. Netherlands Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 178. Netherlands Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 179. Rest of Europe Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 180. Rest of Europe Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 181. Rest of Europe Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 182. MEA Chromoendoscopy Agents, by Country USD Million (2023-2028)
  • Table 183. MEA Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 184. MEA Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 185. MEA Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 186. Middle East Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 187. Middle East Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 188. Middle East Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 189. Africa Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 190. Africa Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 191. Africa Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 192. North America Chromoendoscopy Agents, by Country USD Million (2023-2028)
  • Table 193. North America Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 194. North America Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 195. North America Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 196. United States Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 197. United States Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 198. United States Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 199. Canada Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 200. Canada Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 201. Canada Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 202. Mexico Chromoendoscopy Agents, by Type USD Million (2023-2028)
  • Table 203. Mexico Chromoendoscopy Agents, by Application USD Million (2023-2028)
  • Table 204. Mexico Chromoendoscopy Agents, by By End User USD Million (2023-2028)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Chromoendoscopy Agents: by Type USD Million (2017-2022)
  • Figure 5. Global Chromoendoscopy Agents: by Application USD Million (2017-2022)
  • Figure 6. Global Chromoendoscopy Agents: by By End User USD Million (2017-2022)
  • Figure 7. South America Chromoendoscopy Agents Share (%), by Country
  • Figure 8. Asia Pacific Chromoendoscopy Agents Share (%), by Country
  • Figure 9. Europe Chromoendoscopy Agents Share (%), by Country
  • Figure 10. MEA Chromoendoscopy Agents Share (%), by Country
  • Figure 11. North America Chromoendoscopy Agents Share (%), by Country
  • Figure 12. Global Chromoendoscopy Agents share by Players 2022 (%)
  • Figure 13. Global Chromoendoscopy Agents share by Players (Top 3) 2022(%)
  • Figure 14. Global Chromoendoscopy Agents share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. American Regent, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. American Regent, Inc. (United States) Revenue: by Geography 2022
  • Figure 18. Cerba Research (Belgium) Revenue, Net Income and Gross profit
  • Figure 19. Cerba Research (Belgium) Revenue: by Geography 2022
  • Figure 20. Cosmo Pharmaceuticals NV. (Ireland) Revenue, Net Income and Gross profit
  • Figure 21. Cosmo Pharmaceuticals NV. (Ireland) Revenue: by Geography 2022
  • Figure 22. Enzo Life Sciences, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Enzo Life Sciences, Inc. (United States) Revenue: by Geography 2022
  • Figure 24. LobaChemie Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 25. LobaChemie Pvt. Ltd. (India) Revenue: by Geography 2022
  • Figure 26. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Merck KGaA (Germany) Revenue: by Geography 2022
  • Figure 28. Micro-Tech Endoscopy (United States) Revenue, Net Income and Gross profit
  • Figure 29. Micro-Tech Endoscopy (United States) Revenue: by Geography 2022
  • Figure 30. Provepharm Life Solutions (France) Revenue, Net Income and Gross profit
  • Figure 31. Provepharm Life Solutions (France) Revenue: by Geography 2022
  • Figure 32. Sisco Research Laboratories Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 33. Sisco Research Laboratories Pvt. Ltd. (India) Revenue: by Geography 2022
  • Figure 34. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 35. Thermo Fisher Scientific (United States) Revenue: by Geography 2022
  • Figure 36. Global Chromoendoscopy Agents: by Type USD Million (2023-2028)
  • Figure 37. Global Chromoendoscopy Agents: by Application USD Million (2023-2028)
  • Figure 38. Global Chromoendoscopy Agents: by By End User USD Million (2023-2028)
  • Figure 39. South America Chromoendoscopy Agents Share (%), by Country
  • Figure 40. Asia Pacific Chromoendoscopy Agents Share (%), by Country
  • Figure 41. Europe Chromoendoscopy Agents Share (%), by Country
  • Figure 42. MEA Chromoendoscopy Agents Share (%), by Country
  • Figure 43. North America Chromoendoscopy Agents Share (%), by Country
List of companies from research coverage that are profiled in the study
  • American Regent, Inc. (United States)
  • Cerba Research (Belgium)
  • Cosmo Pharmaceuticals NV. (Ireland)
  • Enzo Life Sciences, Inc. (United States)
  • LobaChemie Pvt. Ltd. (India)
  • Merck KGaA (Germany)
  • Micro-Tech Endoscopy (United States)
  • Provepharm Life Solutions (France)
  • Sisco Research Laboratories Pvt. Ltd. (India)
  • Thermo Fisher Scientific (United States)
Additional players considered in the study are as follows:
Histalim (France) , Medtronic plc. (Ireland) , Boston Scientific (United States)
Select User Access Type

Key Highlights of Report


May 2023 206 Pages 68 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Chromoendoscopy Agents Market Quantitative research analysis
Global Chromoendoscopy Agents Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Chromoendoscopy Agents market are American Regent, Inc. (United States), Cerba Research (Belgium), Cosmo Pharmaceuticals NV. (Ireland), Enzo Life Sciences, Inc. (United States), LobaChemie Pvt. Ltd. (India), Merck KGaA (Germany), Micro-Tech Endoscopy (United States), Provepharm Life Solutions (France), Sisco Research Laboratories Pvt. Ltd. (India) and Thermo Fisher Scientific (United States), to name a few.
"The increasing geriatric population across the globe " is seen as one of major influencing trends for Chromoendoscopy Agents Market during projected period 2022-2028.
Absorptive Agent segment in Global market to hold robust market share owing to "Rise in the number of endoscopy procedures across different developed and developing economies ".

Know More About Global Chromoendoscopy Agents Market Report?

Have a Query? Click Here

Other Related Reports

Crohn Disease Comprehensive Study by Application (Achieving remission (the absence of symptoms), Maintaining remission (prevention of flare-ups), Pediatric Disease), Drug Type (Anti-inflammatory drug...
$ 3750
Lemon Balm Extract Comprehensive Study by End Users (Food & Beverages Industry, Cosmetic Industry, Pharmaceutical Industry, Pesticides Industry, Others), Distribution Channel (Online Stores, Hypermar...
$ 3650
Biperiden Comprehensive Study by Application (Children, Adults), Route of Administration (Oral, Injection) Players and Region - Global Market Outlook to 2026
$ 3500
Food Pharmaceutical Peony Comprehensive Study by Type (Peony Root-Bark Extract, Peony Seed Oil, Peony Essence, Other), Application (Food Industry, Pharmaceutical Industry) Players and Region - Global...
$ 3500
Pharmacy Repackaging System Comprehensive Study by Type (Solid Medication Packaging Systems, Blister Card Packaging Systems, • Multi Dose Blister Card Packaging Systems, • Single Dose Blister Card Pa...
$ 3800
Proton Pump Inhibitor Drug Comprehensive Study by Type (Omeprazole, Lansoprazole, Pantoprazole, Rabeprazole, Others), Application (Hospital, Clinics, Others), Side Effects (Nausea, Headaches, Dry Mou...
$ 3350